The store will not work correctly when cookies are disabled.
(1-(3,4-difluorobenzyl)-1H-1,2,3-triazol-4-yl)methyl cinnamate
ID: ALA4463061
PubChem CID: 155529509
Max Phase: Preclinical
Molecular Formula: C19H15F2N3O2
Molecular Weight: 355.34
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(/C=C/c1ccccc1)OCc1cn(Cc2ccc(F)c(F)c2)nn1
Standard InChI: InChI=1S/C19H15F2N3O2/c20-17-8-6-15(10-18(17)21)11-24-12-16(22-23-24)13-26-19(25)9-7-14-4-2-1-3-5-14/h1-10,12H,11,13H2/b9-7+
Standard InChI Key: TXFARQPKOGAUMN-VQHVLOKHSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
1.6742 -15.2212 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6731 -16.0407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3811 -16.4497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0908 -16.0402 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0880 -15.2176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3793 -14.8123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7941 -14.8063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5034 -15.2122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2095 -14.8010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9188 -15.2069 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.6249 -14.7957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3342 -15.2016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2065 -13.9838 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.4237 -16.0137 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2237 -16.1806 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.6297 -15.4713 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.0805 -14.8662 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.5589 -16.9259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3719 -17.0082 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7043 -17.7515 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5166 -17.8341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9953 -17.1708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6559 -16.4227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8447 -16.3437 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1314 -15.7581 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
11.8084 -17.2520 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 2 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
9 13 2 0
12 14 2 0
14 15 1 0
15 16 1 0
16 17 2 0
17 12 1 0
15 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
23 25 1 0
22 26 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 355.34 | Molecular Weight (Monoisotopic): 355.1132 | AlogP: 3.36 | #Rotatable Bonds: 6 |
Polar Surface Area: 57.01 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 4.38 | CX LogD: 4.38 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.50 | Np Likeness Score: -1.67 |
References
1. Rodrigues MP, Tomaz DC, Ângelo de Souza L, Onofre TS, Aquiles de Menezes W, Almeida-Silva J, Suarez-Fontes AM, Rogéria de Almeida M, Manoel da Silva A, Bressan GC, Vannier-Santos MA, Rangel Fietto JL, Teixeira RR.. (2019) Synthesis of cinnamic acid derivatives and leishmanicidal activity against Leishmania braziliensis., 183 [PMID:31542714] [10.1016/j.ejmech.2019.111688] |